Celgene Corporation:企業の戦略・SWOT・財務情報

◆英語タイトル:Celgene Corporation - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C4436
◆発行会社(調査会社):MarketLine
◆発行日:2018年8月
◆ページ数:63
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Celgene Corporation – Strategy, SWOT and Corporate Finance Report
Summary

Celgene Corporation – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Celgene Corporation (Celgene or ‘the company’) is an integrated biopharmaceutical company that is primarily involved in the research, development and marketing of novel therapies for the treatment of cancer and inflammatory diseases through next-generation solutions in protein homeostasis, immuno-oncology, epigenetics, immunology and neuro-inflammation. These are marketed under IMNOVID, REVLIMID, THALOMID and VIDAZA, to mention a few. It sells these products through wholesale distributors and specialty pharmacies in the US and its international sales are made directly to hospitals, clinics and retail chains, many of which are government owned. The company operates in the US, Europe and other countries. Celgene is headquartered in Summit, New Jersey, the US.

Scope

- Detailed information on Celgene Corporation required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Celgene Corporation in the form of a SWOT analysis
- An in-depth view of the business model of Celgene Corporation including a breakdown and examination of key business segments
- Intelligence on Celgene Corporation’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Celgene Corporation, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Celgene Corporation and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Celgene Corporation as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Celgene Corporation’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Celgene Corporation: Company Overview 9
Celgene Corporation: Overview and Key Facts 9
Celgene Corporation: Overview 9
Celgene Corporation: Key Facts 9
Celgene Corporation: Key Employees 11
Celgene Corporation: Key Employee Biographies 12
Celgene Corporation: Major Products and Services 17
Celgene Corporation: Company History 19
Celgene Corporation: Management Statement 26
Celgene Corporation: Locations and Subsidiaries 30
Celgene Corporation: Key Competitors 32
Celgene Corporation: Company Analysis 33
Celgene Corporation: Business Description 33
Celgene Corporation: SWOT Analysis 35
Celgene Corporation: SWOT Overview 35
Celgene Corporation: Strengths 35
Celgene Corporation: Weaknesses 36
Celgene Corporation: Opportunities 36
Celgene Corporation: Threats 38
Celgene Corporation: Corporate Financial Deals Activity 39
Celgene Corporation: Financial Deals Overview 39
Celgene Corporation: Targets and Partners 41
Celgene Corporation: Top Deals 2014 – 2018YTD* 45
Celgene Corporation: Advisors 46
Celgene Corporation: Top Legal Advisors 46
Celgene Corporation: Top Financial Advisors 46
Celgene Corporation: Mergers and Acquisitions 48
Celgene Corporation: Corporate Venturing 49
Celgene Corporation: Capital Raising 50
Celgene Corporation: Partnership 51
Celgene Corporation: Recent Developments 52
Celgene Corporation: News and Events Summary 52
Celgene Corporation: Business Expansion 56
Celgene Corporation: Corporate Governance 56
Celgene Corporation: Financial Performance 57
Celgene Corporation: Market Developments 57
Celgene Corporation: Regulatory and Legal Events 59
Celgene Corporation: Strategy and Operations 60
Appendix 61
Contact Us 61
Methodology 61
About MarketLine 62

List of Tables
Table 1: Celgene Corporation: Key Facts
Table 2: Celgene Corporation: Key Employees
Table 3: Celgene Corporation: Locations and Subsidiaries
Table 4: Celgene Corporation: Key Competitors
Table 5: Celgene Corporation: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Celgene Corporation: M&A Activity by Geography (TTM*)
Table 7: Celgene Corporation: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 8: Celgene Corporation: M&A Average Deal Size - Value (US$m)
Table 9: Celgene Corporation: Targets and Partners
Table 10: Celgene Corporation: Top Deals 2014 - 2018YTD*
Table 11: Celgene Corporation: Legal Advisor Ranking by Value (US$m)
Table 12: Celgene Corporation: Financial Advisor Ranking by Value (US$m)
Table 13: Celgene Corporation: M&A Volume and Value Trend (2014 - YTD*2018)
Table 14: Celgene Corporation: M&A Activity by Geography (2014 - YTD*2018)
Table 15: Celgene Corporation: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Table 16: Celgene Corporation: Corporate Venturing by Geography (2014 - YTD*2018)
Table 17: Celgene Corporation: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Table 18: Celgene Corporation: Capital Raising by Deal Type (2014 - YTD*2018)
Table 19: Celgene Corporation: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 20: Celgene Corporation: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 21: Celgene Corporation: News and Events Summary
Table 22: Celgene Corporation: Business Expansion
Table 23: Celgene Corporation: Corporate Governance
Table 24: Celgene Corporation: Financial Performance
Table 25: Celgene Corporation: Market Developments
Table 26: Celgene Corporation: Regulatory and Legal Events
Table 27: Celgene Corporation: Strategy and Operations

List of Figures
Figure 1: Celgene Corporation: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Celgene Corporation: M&A Activity by Geography (TTM*)
Figure 3: Celgene Corporation: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 4: Celgene Corporation: M&A Average Deal Size - Value (US$m)
Figure 5: Celgene Corporation: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 6: Celgene Corporation: M&A Activity by Geography (2014 - YTD*2018)
Figure 7: Celgene Corporation: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Figure 8: Celgene Corporation: Corporate Venturing by Geography (2014 - YTD*2018)
Figure 9: Celgene Corporation: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Figure 10: Celgene Corporation: Capital Raising by Deal Type (2014 - YTD*2018)
Figure 11: Celgene Corporation: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 12: Celgene Corporation: Partnership Trend by Deal Type (2014 - YTD*2018)

★海外企業調査レポート[Celgene Corporation:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • San Juan Basin Royalty Trust (SJT):企業の財務・戦略的SWOT分析
    Summary San Juan Basin Royalty Trust (SJT) is a trust that has overriding royalty interest divided out of Southland Royalty's oil and gas leasehold and royalty interest in the San Juan Basin of northwestern New Mexico. The trust’s underlying properties include royalty interests, overriding royalty i …
  • ZIOPHARM Oncology Inc (ZIOP):企業の財務・戦略的SWOT分析
    Summary Ziopharm Oncology Inc (Ziopharm), is a provider of next-generation immune therapies. The company offers Controlled IL-12 and t-cell therapy to fight blood cancers and solid tumors. Its Controlled IL-12 platform provides therapy for cold tumors by turning them hot by activating an immune resp …
  • Globe Telecom Inc (GLO):企業の財務・戦略的SWOT分析
    Globe Telecom Inc (GLO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Checkmate Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Checkmate Pharmaceuticals Inc (Checkmate Pharmaceuticals) is a clinical stage company that discovers and develops immunotherapies to provide new treatment options for patients and the healthcare providers. The company’s lead product candidate, CMP-001, is a CpG oligonucleotides (CpG-A ODN) t …
  • Heska Corp (HSKA):企業の財務・戦略的SWOT分析
    Heska Corp (HSKA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Metalico Inc:企業の戦略的SWOT分析
    Metalico Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Ypsomed Holding AG (YPSN)-医療機器分野:企業M&A・提携分析
    Summary Ypsomed Holding AG (Ypsomed) is a medical device company. It designs, develops and manufactures injection systems. Its offers pen injectors, autoinjectors, dual chamber pens and other custom products. The company also offers contract manufacturing, industrial design, human factors engineerin …
  • Lyka Labs Ltd (LYKALABS):企業の財務・戦略的SWOT分析
    Summary Lyka Labs Ltd (Lyka Labs) is a manufacturer of pharmaceutical formulations and active pharmaceutical ingredients. The company provides formulations such as lyophilized injections, topical formulations of cream, ointment, foams, gels and lotions. It offers formulation research and development …
  • Siltech Corp:企業の戦略的SWOT分析
    Siltech Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Nacco Industries Inc:企業の戦略・SWOT・財務情報
    Nacco Industries Inc - Strategy, SWOT and Corporate Finance Report Summary Nacco Industries Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Flowserve Corporation:企業の戦略・SWOT・財務情報
    Flowserve Corporation - Strategy, SWOT and Corporate Finance Report Summary Flowserve Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • The Blackstone Group LP:企業の戦略・SWOT・財務情報
    The Blackstone Group LP - Strategy, SWOT and Corporate Finance Report Summary The Blackstone Group LP - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • eNeura Inc:医療機器:M&Aディール及び事業提携情報
    Summary eNeura Inc (eNeura) formerly eNeura Therapeutics LLC is a medical device manufacturing company that offers portable, non-invasive transcranial magnetic stimulation devices for treating migraine. The company offers products such as flagship product and eNeura Spring TMS device, among others. …
  • Sumitomo Realty & Development Co., Ltd.
    Sumitomo Realty & Development Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Sumitomo Realty & Development Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • LEO Pharma AS-医療機器分野:企業M&A・提携分析
    Summary LEO Pharma A/S (LEO Pharma) is a research-based pharmaceutical company. It undertakes the discovery, development, manufacture and commercialization of pharmaceuticals in the therapeutic areas dermatology and thrombosis. The company focuses on the treatment of diseases such as psoriasis, ecze …
  • Bone Biologics Corp (BBLG):企業の製品パイプライン分析
    Summary Bone Biologics Corp (Bone Biologics) is a biotechnology company that develops orthobiologic products. It develops NELL-1, a recombinant human protein growth factor, which is essential for normal bone development. It offers bone graft substitutes for spine fusion. Bone Biologics also offers N …
  • BioNano Genomics Inc:医療機器:M&Aディール及び事業提携情報
    Summary BioNano Genomics Inc (BioNano) is a developer of technology platform to analyze the segments of genomic DNA and other structural variations. The company's products include irys chip, saphyr, genome mapping systems and prep kits. Its saphyr offers breakthrough speed and throughput with unmatc …
  • Beckman Coulter, Inc.:企業のM&A・事業提携・投資動向
    Beckman Coulter, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Beckman Coulter, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Kresta Holdings Limited (KRS):企業の財務・戦略的SWOT分析
    Kresta Holdings Limited (KRS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • University of Aberdeen-製薬・医療分野:企業M&A・提携分析
    Summary University of Aberdeen (UOA) is an educational and research institution that offers undergraduate, graduate, postgraduate and research programs in a range of subjects. The university offers undergraduate and postgraduate courses in the areas of arts, creative arts, commerce, education, engin …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆